Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

461 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ambulatory blood pressure monitoring for risk stratification in obese and non-obese subjects from 10 populations.
Hansen TW, Thijs L, Li Y, Boggia J, Liu Y, Asayama K, Kikuya M, Björklund-Bodegård K, Ohkubo T, Jeppesen J, Torp-Pedersen C, Dolan E, Kuznetsova T, Stolarz-Skrzypek K, Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Lind L, Sandoya E, Kawecka-Jaszcz K, Filipovský J, Imai Y, Wang J, O'Brien E, Staessen JA. Hansen TW, et al. J Hum Hypertens. 2014 Sep;28(9):535-42. doi: 10.1038/jhh.2013.145. Epub 2014 Jan 16. J Hum Hypertens. 2014. PMID: 24430701
Pulse pressure is not an independent predictor of outcome in type 2 diabetes patients with chronic kidney disease and anemia--the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT).
Theilade S, Claggett B, Hansen TW, Skali H, Lewis EF, Solomon SD, Parving HH, Pfeffer M, McMurray JJ, Rossing P; TREAT investigators. Theilade S, et al. Among authors: hansen tw. J Hum Hypertens. 2016 Jan;30(1):46-52. doi: 10.1038/jhh.2015.22. Epub 2015 Mar 26. J Hum Hypertens. 2016. PMID: 25810068 Clinical Trial.
Circulating metabolomic markers in association with overall burden of microvascular complications in type 1 diabetes.
Rotbain Curovic V, Sørland BA, Hansen TW, Jain SY, Sulek K, Mattila IM, Frimodt-Moller M, Trost K, Legido-Quigley C, Theilade S, Tofte N, Winther SA, Hansen CS, Rossing P, Ahluwalia TS. Rotbain Curovic V, et al. Among authors: hansen cs, hansen tw. BMJ Open Diabetes Res Care. 2024 Apr 11;12(2):e003973. doi: 10.1136/bmjdrc-2023-003973. BMJ Open Diabetes Res Care. 2024. PMID: 38604732 Free PMC article.
Extracellular matrix turnover proteins as risk markers in people with type 2 diabetes and microalbuminuria.
Skriver-Møller AC, Møller AL, Blond MB, Rasmussen DGK, Genovese F, Reinhard H, von Scholten BJ, Jacobsen PK, Parving HH, Karsdal MA, Hansen TW, Rossing P. Skriver-Møller AC, et al. Among authors: hansen tw. J Diabetes Complications. 2024 Jun;38(6):108765. doi: 10.1016/j.jdiacomp.2024.108765. Epub 2024 May 7. J Diabetes Complications. 2024. PMID: 38749295
Endothelial dysfunction markers syndecan-1 and thrombomodulin are associated with higher albuminuria levels in type 2 diabetes with no history of clinical cardiovascular disease.
Ferreira-Divino LF, Poulsen CG, Rotbain Curovic V, Pedersen OB, Tofte N, Frimodt-Møller M, Hansen TW, Hvas AM, Rossing P. Ferreira-Divino LF, et al. Among authors: hansen tw. J Diabetes Complications. 2024 Nov;38(11):108879. doi: 10.1016/j.jdiacomp.2024.108879. Epub 2024 Oct 9. J Diabetes Complications. 2024. PMID: 39405782
461 results